MedTrace Logo

Observation in Patients With Early-Stage Vulvar Cancer Undergoing Sentinel Lymph Node Dissection

NCT01500512 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 148

Last updated 2021-09-30

No results posted yet for this study

Summary

This research trial studies patients with early-stage vulvar cancer undergoing sentinel lymph node dissection. Sentinel lymph node dissection may have fewer side effects than removing all lymph nodes. Observing patients undergoing sentinel lymph node dissection may help doctors confirm the safety of the procedure.

Conditions

  • Stage I Vulvar Cancer
  • Stage II Vulvar Cancer
  • Stage III Vulvar Cancer
  • Vulvar Squamous Cell Carcinoma

Interventions

OTHER

Clinical Observation

Undergo observation

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Gynecologic Oncology Group

    lead NETWORK

Principal Investigators

  • Brian Slomovitz · NRG Oncology

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-03
Primary Completion
2022-07-01

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01500512 on ClinicalTrials.gov